BREVIBACTERIUM INFECTION

BREVIBACTERIUM INFECTION was reported 9 times

BREVIBACTERIUM INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
1 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
2 Sigma-1 Agonist [EPC] 1 0.0001
3 Non-narcotic Antitussive [EPC] 1 0.0001
4 Orexin Receptor Antagonist [EPC] 1 0.0001
5 Leukocyte Growth Factor [EPC] 3 0.0000
6 Complement Inhibitor [EPC] 1 0.0000
7 Topoisomerase Inhibitor [EPC] 1 0.0000
8 Integrin Receptor Antagonist [EPC] 1 0.0000
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
10 Purine Antimetabolite [EPC] 1 0.0000
11 Interleukin-12 Antagonist [EPC] 1 0.0000
12 Interleukin-23 Antagonist [EPC] 1 0.0000
13 Fluoroquinolone Antibacterial [EPC] 1 0.0000
14 Prostacycline Vasodilator [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
16 Calcium [EPC] 1 0.0000
17 Azole Antifungal [EPC] 1 0.0000
18 Janus Kinase Inhibitor [EPC] 1 0.0000
19 Endothelin Receptor Antagonist [EPC] 1 0.0000
20 Platinum-based Drug [EPC] 1 0.0000
21 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
22 Factor Xa Inhibitor [EPC] 1 0.0000
23 Osmotic Laxative [EPC] 1 0.0000
24 Vitamin D [EPC] 1 0.0000
25 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
26 Vitamin B12 [EPC] 1 0.0000
27 Vitamin C [EPC] 1 0.0000
28 Corticosteroid [EPC] 3 0.0000
29 Atypical Antipsychotic [EPC] 1 0.0000
30 Kinase Inhibitor [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000